| Literature DB >> 18490738 |
Judy L Cannon1, Amélie Collins, Purvi D Mody, Diwaker Balachandran, Kammi J Henriksen, Cassandra E Smith, Jiankun Tong, Bryan S Clay, Stephen D Miller, Anne I Sperling.
Abstract
CD43 is a highly glycosylated transmembrane protein that regulates T cell activation. CD43(-/-) T cells are hyperproliferative and the cytoplasmic tail of CD43 has been found to be sufficient to reconstitute wild-type proliferation levels, suggesting an intracellular mechanism. In this study, we report that upon TCR ligation CD43(-/-) T cells demonstrated no increase in tyrosine phosphorylation but a decreased calcium flux. Interestingly, CD43(-/-) T cells preferentially differentiated into Th2 cells in vitro, and CD43(-/-) T cells show increased GATA-3 translocation into the nucleus. In vivo, CD43(-/-) mice exhibited increased inflammation in two separate models of Th2-mediated allergic airway disease. In contrast, in Th1-mediated diabetes, nonobese diabetic CD43(-/-) mice did not significantly differ from wild-type mice in disease onset or progression. Th1-induced experimental autoimmune encephalomyelitis to MOG(35-55) was also normal in the CD43(-/-) mice. Nonetheless, the CD43(-/-) mice produced more IL-5 when restimulated with MOG(35-55) in vitro and demonstrated decreased delayed-type hypersensitivity responses. Together, these data demonstrate that although CD43(-/-) T cells preferentially differentiate into Th2 cells, this response is not sufficient to protect against Th1-mediated autoimmune responses.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18490738 PMCID: PMC2669414 DOI: 10.4049/jimmunol.180.11.7385
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422